BURAN: Effects of BenralizUmab on AiRwAy DyNamics in Severe Eosinophilic Asthma using Functional Respiratory Imaging Parameters

Grants and Contracts Details

StatusFinished
Effective start/end date2/28/23 → 1/11/25

Funding

  • AstraZeneca Pharmaceuticals AB: $43,294.00